CYCLOPHARM LIMITED — Director's Dealing 2014

Mar 5, 2014

==> picture [151 x 48] intentionally omitted <==

6 March 2014

The Manager Company Announcements Office Australian Securities Exchange Limited 20 Bridge Street Sydney NSW 2000

cyclocyclo medica medica technemolecular gas imaging cyclotechne pet gas

Cyclopharm Ltd Cyclopharm Ltd ABN 74 116 931 250 ABN 74 116 931 250 Bldg 75 Business & Technology Park Bldg 75 Business & Technology Park New Illawarra Road New Illawarra Road Lucas Heights NSW 2234 Australia Lucas Heights NSW 2234 Australia POB 350 Menai Central NSW 2234 POB 350 Menai Central NSW 2234 T 61 2 9541 0411 T 61 2 9541 0411 F 61 2 9543 0960 F 61 2 9543 0960 www.cyclopharm.com.au www.cyclopharm.com.au

Correction in Appendix 3X of Henry Townsing

We attach the amended Appendix 3X of Henry Townsing and set out the differences below :

Correction in Appendix 3X of Henry TownsingWe attach the amended Appendix 3X of Henry Townsing and set out the differences below :
	Original		Corrected	Comment
			*****
Direct Shares	19	636	0	Owned by Henry
	,			Townsing (child)
Indirect Shares
Edward Townsing	3,0	00	0*
(child)
Henry Townsing	4,4	00	0*
(father’s estate)
Henry Townsing(child)	4,9	09	0*
Lloyd Townsing	3,0	00	0*
(child)
Pilmora Pty Ltd(Director)	22	,268	227,268
Gaynor Townsing	2,5	18	2,518
(spouse)
Total Indirect Shares	245,095		229,786
Total Direct andIndirect Shares	264,731		229,786

*Excluded from amended Appendix 3X as the Director has no control or influence over these shares as the shares are held by his adult children / executor of his father’s estate.

For more information, please contact either:

Mr James McBrayer Managing Director, CEO and Company Secretary Cyclopharm Limited T: +61 (02) 9541 0411

Page 1 of 1

Appendix 3X Initial Director’s Interest Notice

Rule 3.19A.1

Appendix 3X (amended)

Initial Director’s Interest Notice

Name of entity CYCLOPHARM LIMITED ABN 74 116 931 250

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Henry George Townsing
Date of appointment	16/9/2013

Part 1 - Director’s relevant interests in securities of which the director is the registered holder

Number & class of securities
Ordinary Shares	0
Direct:	0

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of interest	Number & class of Securities
Pilmora Pty Ltd (Director) Gaynor Townsing (spouse)	Ordinary Shares227,268Ordinary Shares 2,518
Indirect	229,786
Total (Direct & Indirect):	229,786

• See chapter 19 for defined terms.

Appendix 3X Page 1

11/3/2002

Appendix 3X Initial Director’s Interest Notice

Part 3 – Director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	Nil
Nature of interest	Nil
Name of registered holder(if issued securities)	Nil
No. and class of securities towhich interest relates	Nil

• See chapter 19 for defined terms.

Appendix 3X Page 2

11/3/2002